03:26 AM EDT, 10/29/2025 (MT Newswires) -- Charles A Rowland Jr, Director, on October 27, 2025, sold 60,000 shares in Viking Therapeutics ( VKTX ) for $2,134,278. Following the Form 4 filing with the SEC, Rowland has control over a total of 30,000 common shares of the company, with 30,000 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1607678/000119312525254300/xslF345X05/ownership.xml